Skip to main content

Advertisement

SpringerLink
Log in

Imaging bile duct tumors: staging

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Cholangiocarcinoma (CC) is the most frequent neoplasm of the biliary system. According to its anatomic origin in the biliary tree it is usually classified as intrahepatic, perihilar, or extrahepatic distal CC. Tumors originated in these areas differ in biological behavior and management. The stratification of the patients aligned to therapeutic options and prognosis is a key point in the management of CC. Thus, specific staging systems have been designed for each anatomical location. They are precise for surgical planning, to establish prognosis after surgery, or to compare the benefits of different therapeutic approaches, but they are less accurate to stratify patients into a therapeutic decision algorithm. Imaging tools, mainly multidetector computed tomography and magnetic resonance imaging (MRI), allow full assessment of the diagnosis and extension of the tumor. They are especially useful in establishing the correct diagnosis and determining resectability, which reaches a high negative predictive value, identifying those patients in whom surgery will not be effective. We will discuss the different staging systems for CC, the radiologic characteristics with classical and recently described signs that allow a confident diagnosis of the disease and the criteria for resectability of biliary tract malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Yamasaki S (2003) Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 10:288–291

    Article  PubMed  Google Scholar 

  2. Razumilava N, Gores GJ (2013) Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol 11:13–21

    Article  PubMed  Google Scholar 

  3. Deoliveira ML, Schulick RD, Nimura Y, et al. (2011) New staging system and a registry for perihilar cholangiocarcinoma. Hepatology 53:1363–1371

    Article  PubMed  Google Scholar 

  4. Blechacz B, Komuta M, Roskams T, Gores GJ (2011) Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 8:512–522

    Article  PubMed  Google Scholar 

  5. Deoliveira ML, Cunningham SC, Cameron JL, et al. (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755–762

    Article  PubMed  Google Scholar 

  6. Singh MK, Facciuto ME (2012) Current management of cholangiocarcinoma. Mt Sinai J Med 79:232–245

    Article  PubMed  Google Scholar 

  7. Jonas S, Thelen A, Benckert C, et al. (2009) Extended liver resection for intrahepatic cholangiocarcinoma: a comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification. Ann Surg 249:303–309

    Article  PubMed  Google Scholar 

  8. Lang H, Sotiropoulos GC, Sgourakis G, et al. (2009) Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg 208:218–228

    Article  PubMed  Google Scholar 

  9. Uenishi T, Kubo S, Yamazaki O, et al. (2008) Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg 15:417–422

    Article  PubMed  Google Scholar 

  10. Nathan H, Aloia TA, Vauthey JN, et al. (2009) A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 16:14–22

    Article  PubMed  Google Scholar 

  11. Edge SB (2009) American Joint Committee on Cancer: AJCC cancer staging manual, 7th edn. New York: Springer

    Google Scholar 

  12. Farges O, Fuks D, Le Treut YP, et al. (2011) AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 Study Group. Cancer 117:2170–2177

    Article  PubMed  Google Scholar 

  13. Sotiropoulos GC, Miyazaki M, Konstadoulakis MM, et al. (2010) Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomas. Liver Int 30:996–1002

    Article  PubMed  Google Scholar 

  14. Marsh RW, Alonzo M, Bajaj S, et al. (2012) Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part I: diagnosis-clinical staging and pathology. J Surg Oncol 106:332–338

    Article  Google Scholar 

  15. Valls C, Guma A, Puig I, et al. (2000) Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 25:490–496

    Article  PubMed  CAS  Google Scholar 

  16. Kim SA, Lee JM, Lee KB, et al. (2011) Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern—correlation with clinicopathologic findings. Radiology 260:148–157

    Article  PubMed  Google Scholar 

  17. Rimola J, Forner A, Reig M, et al. (2009) Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 50:791–798

    Article  PubMed  Google Scholar 

  18. Park HJ, Kim YK, Park MJ, Lee WJ (2012) Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom Imaging. doi:10.1007/s00261-012-9943-x

  19. Vilgrain V, Van Beers BE, Flejou JF, et al. (1997) Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 21:59–65

    Article  PubMed  CAS  Google Scholar 

  20. Okabayashi T, Yamamoto J, Kosuge T, et al. (2001) A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 92:2374–2383

    Article  PubMed  CAS  Google Scholar 

  21. Kang Y, Lee JM, Kim SH, Han JK, Choi BI (2012) Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 264:751–760

    Article  PubMed  Google Scholar 

  22. Vilgrain V (2008) Staging cholangiocarcinoma by imaging studies. HPB (Oxford) 10:106–109

    Article  CAS  Google Scholar 

  23. Kim JY, Kim MH, Lee TY, et al. (2008) Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterol 103:1145–1151

    Article  PubMed  Google Scholar 

  24. Lee SW, Kim HJ, Park JH, et al. (2010) Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma. J Gastroenterol 45:560–566

    Article  PubMed  Google Scholar 

  25. Corvera CU, Blumgart LH, Akhurst T, et al. (2008) 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg 206:57–65

    Article  PubMed  Google Scholar 

  26. Marsh RW, Alonzo M, Bajaj S, et al. (2012) Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part II: multidisciplinary management. J Surg Oncol 106:339–345

    Article  Google Scholar 

  27. Dhanasekaran R, Hemming AW, Zendejas I, et al. (2013) Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma. Oncol Rep 29:1259–1267

    PubMed  CAS  Google Scholar 

  28. Bismuth H, Corlette MB (1975) Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 140:170–178

    PubMed  CAS  Google Scholar 

  29. Jarnagin WR, Fong Y, DeMatteo RP, et al. (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507–517

    Article  PubMed  CAS  Google Scholar 

  30. Matsuo K, Rocha FG, Ito K, et al. (2012) The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg 215:343–355

    Article  PubMed  Google Scholar 

  31. Zervos EE, Osborne D, Goldin SB, et al. (2005) Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach. Am J Surg 190:810–815

    Article  PubMed  Google Scholar 

  32. Nagino M (2011) Perihilar cholangiocarcinoma: a much needed but imperfect new staging system. Nat Rev Gastroenterol Hepatol 8:252–253

    PubMed  Google Scholar 

  33. Gore RM, Shelhamer RP (2007) Biliary tract neoplasms: diagnosis and staging. Cancer Imaging 7 Spec No A:S15–S23

    Google Scholar 

  34. Masselli G, Gualdi G (2008) Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning. Abdom Imaging 33:444–451

    Article  PubMed  Google Scholar 

  35. Tirapu de Sagrario MG, Baleato GS, Garcia FR, Coessens A (2013) Intraductal biliary metastases from colorectal cancer: a report of two cases. Radiologia. doi:10.1016/j.rx.2013.01.005

  36. Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD (2008) Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology 48:1106–1117

    Article  PubMed  CAS  Google Scholar 

  37. Cui XY, Chen HW (2010) Role of diffusion-weighted magnetic resonance imaging in the diagnosis of extrahepatic cholangiocarcinoma. World J Gastroenterol 16:3196–3201

    Article  PubMed  Google Scholar 

  38. Cui XY, Chen HW, Cai S, et al. (2012) Diffusion-weighted MR imaging for detection of extrahepatic cholangiocarcinoma. Eur J Radiol 81:2961–2965

    Article  PubMed  Google Scholar 

  39. Kim JE, Lee JM, Kim SH, et al. (2010) Differentiation of intraductal growing-type cholangiocarcinomas from nodular-type cholangiocarcinomas at biliary MR imaging with MR cholangiography. Radiology 257:364–372

    Article  PubMed  Google Scholar 

  40. Takanami K, Yamada T, Tsuda M, et al. (2011) Intraductal papillary mucininous neoplasm of the bile ducts: multimodality assessment with pathologic correlation. Abdom Imaging 36:447–456

    Article  PubMed  Google Scholar 

  41. Choi JY, Kim MJ, Lee JM, et al. (2008) Hilar cholangiocarcinoma: role of preoperative imaging with sonography, MDCT, MRI, and direct cholangiography. AJR Am J Roentgenol 191:1448–1457

    Article  PubMed  Google Scholar 

  42. Hattori M, Nagino M, Ebata T, et al. (2011) Prospective study of biliary cytology in suspected perihilar cholangiocarcinoma. Br J Surg 98:704–709

    Article  PubMed  CAS  Google Scholar 

  43. Halling KC, Kipp BR (2007) Fluorescence in situ hybridization in diagnostic cytology. Hum Pathol 38:1137–1144

    Article  PubMed  CAS  Google Scholar 

  44. Lee HY, Kim SH, Lee JM, et al. (2006) Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 239:113–121

    Article  PubMed  Google Scholar 

  45. Kim HJ, Kim AY, Hong SS, et al. (2006) Biliary ductal evaluation of hilar cholangiocarcinoma: three-dimensional direct multi-detector row CT cholangiographic findings versus surgical and pathologic results—feasibility study. Radiology 238:300–308

    Article  PubMed  Google Scholar 

  46. Masselli G, Manfredi R, Vecchioli A, Gualdi G (2008) MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings. Eur Radiol 18:2213–2221

    Article  PubMed  Google Scholar 

  47. Aloia TA, Charnsangavej C, Faria S, et al. (2007) High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. Am J Surg 193:702–706

    Article  PubMed  Google Scholar 

  48. Forsmo HM, Horn A, Viste A, Hoem D, Ovrebo K (2008) Survival and an overview of decision-making in patients with cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 7:412–417

    PubMed  Google Scholar 

  49. Sacks A, Peller PJ, Surasi DS, et al. (2011) Value of PET/CT in the management of primary hepatobiliary tumors, part 2. AJR Am J Roentgenol 197:W260–W265

    Article  PubMed  Google Scholar 

  50. Ruys AT, van Beem BE, Engelbrecht MR, et al. (2012) Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis. Br J Radiol 85:1255–1262

    Article  PubMed  CAS  Google Scholar 

  51. Hong SM, Pawlik TM, Cho H, et al. (2009) Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma. Surgery 146:250–257

    Article  PubMed  Google Scholar 

  52. Murakami Y, Uemura K, Sudo T, et al. (2010) Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma. J Am Coll Surg 211:196–204

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiology Department, Centre de Diagnòstic per la Imatge Clínic (CDIC), Hospital Clínic, C/Villarroel 170, 08036, Barcelona, Spain

    Juan-Ramón Ayuso, Mario Pagés & Anna Darnell

Authors
  1. Juan-Ramón Ayuso
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mario Pagés
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna Darnell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Juan-Ramón Ayuso.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ayuso, JR., Pagés, M. & Darnell, A. Imaging bile duct tumors: staging. Abdom Imaging 38, 1071–1081 (2013). https://doi.org/10.1007/s00261-013-0021-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-013-0021-9

Keywords

Search

Navigation